CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 204 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $137,000 | -28.6% | 11,300 | -16.9% | 0.06% | -33.3% |
| Q3 2019 | $192,000 | +43.3% | 13,600 | +12.9% | 0.08% | +44.8% |
| Q2 2019 | $134,000 | +3.1% | 12,046 | +9.1% | 0.06% | +3.6% |
| Q1 2019 | $130,000 | -47.6% | 11,046 | -40.5% | 0.06% | -67.1% |
| Q4 2018 | $248,000 | -87.2% | 18,574 | -86.6% | 0.17% | -74.9% |
| Q3 2018 | $1,940,000 | -9.9% | 138,374 | +1.1% | 0.68% | -13.6% |
| Q2 2018 | $2,152,000 | -4.3% | 136,874 | +0.1% | 0.78% | +1.6% |
| Q1 2018 | $2,249,000 | -10.4% | 136,696 | -1.6% | 0.77% | -17.4% |
| Q4 2017 | $2,509,000 | -12.7% | 138,946 | -6.7% | 0.94% | -21.4% |
| Q3 2017 | $2,875,000 | +62.4% | 148,946 | -0.7% | 1.19% | +49.4% |
| Q2 2017 | $1,770,000 | +7.3% | 149,996 | -0.3% | 0.80% | -4.9% |
| Q1 2017 | $1,649,000 | +51.0% | 150,496 | +0.0% | 0.84% | +47.5% |
| Q4 2016 | $1,092,000 | – | 150,422 | – | 0.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,340,193 | $227,229 | 10.94% |
| Novo Holdings A/S | 3,377,768 | $92,044,178 | 6.80% |
| Parallel Advisors, LLC | 3,723,483 | $101,446,294 | 3.38% |
| TANAKA CAPITAL MANAGEMENT INC | 37,569 | $1,024 | 2.92% |
| S&T BANK/PA | 334,252 | $9,107 | 1.76% |
| Birchview Capital, LP | 50,000 | $1,362,250 | 1.16% |
| Granite Investment Partners, LLC | 798,552 | $21,756,549 | 0.91% |
| FAS Wealth Partners, Inc. | 310,764 | $8,466,766 | 0.90% |
| Clearview Wealth Advisors LLC | 25,258 | $688,155 | 0.85% |
| Bridge City Capital, LLC | 43,485 | $1,184,749 | 0.60% |